Trials / Active Not Recruiting
Active Not RecruitingNCT07269587
A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19
A Retrospective, Observational, and Multicenter Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 275 (actual)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study is a retrospective, observational, and multicenter post marketing real-world study aimed at evaluating the efficacy and safety of CNCT-19 in the treatment of Chinese adult B-cell acute lymphoblastic leukemia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CNCT-19 | All patients have received CNCT-19 |
Timeline
- Start date
- 2025-11-07
- Primary completion
- 2027-11-30
- Completion
- 2027-11-30
- First posted
- 2025-12-08
- Last updated
- 2025-12-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07269587. Inclusion in this directory is not an endorsement.